查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654175

免疫蛋白診斷測試市場規模、佔有率、趨勢分析報告：按測試、技術、最終用途、分銷管道、地區和細分市場、預測，2025-2030 年

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

免疫蛋白診斷測試市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球免疫蛋白診斷檢測市場規模預計到2030年將達到148.6億美元，2025年至2030年期間的複合年成長率為7.7%。

這種成長是由慢性病患病率上升所推動的。

根據美國心臟協會2017年統計，美國每年有近79萬人心臟病發作，美國每20人就有1人死於中風。由於上述因素，免疫蛋白診斷的需求預計將會增加，以促進快速診斷。

根據世界衛生組織統計，2015年全球有近169萬人死於肺癌。因此，快速且準確地診斷此類慢性疾病對於降低高死亡率至關重要。免疫蛋白診斷設備和試劑已被證明在快速檢測慢性疾病方面非常有效。

免疫蛋白診斷領域的技術進步正在推動新產品的採用。例如，DiaSorin 的 LIAISON XL 是一款全自動化學冷光分析儀，可實現完整的樣品處理。它還測量和評估測試樣本，提高系統效率和吞吐量。

免疫蛋白診斷測試市場報告重點

  • 免疫球蛋白診斷測試部分在 2024 年佔據最大的市場收益佔有率，為 27.1%。這些測試佔據了免疫蛋白診斷測試市場主導地位，因為它們在診斷多種疾病（包括免疫力缺乏、自體免疫疾病和感染疾病）中發揮著至關重要的作用。
  • 傳染病檢查領域在2024年佔據市場最大的收入佔有率，佔24.2%。由於感染疾病率不斷上升、需要早期準確診斷以及傳染病檢測在公共衛生管理中發揮重要作用，因此對傳染病檢查檢測的需求很高。
  • 2024 年，基於酵素的免疫測量部分佔據市場最大的收益佔有率，為 25.0%。
  • 2024 年零售部分佔比最大，為 54.1%。這種成長歸因於患者的可及性和便利性的提高。
  • 2024 年，醫院和診所部門佔據市場最大的收入佔有率，達到 44.7%。由於醫院和診所每天接待的患者數量龐大，因此對診斷檢測服務的需求很高。
  • 北美將主導免疫蛋白診斷檢測產業，到 2024 年將佔 45.32% 的佔有率。市場主導地位歸因於技術進步、慢性病的高盛行率以及研發投入的不斷增加。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 免疫蛋白診斷測試市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 免疫蛋白診斷測試市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章免疫蛋白診斷測試市場：按測試進行估計和趨勢分析

  • 2024 年和 2030 年的測試市場佔有率
  • 細分儀表板
  • 全球免疫蛋白診斷檢測市場前景
  • 2018-2030 年市場規模、預測及趨勢分析
    • 補體系統蛋白診斷測試
    • 免費輕鏈診斷測試
    • 結合球蛋白診斷測試
    • 免疫球蛋白診斷測試
    • 前白蛋白診斷測試
    • C反應蛋白（CRP）診斷測試

第 5 章免疫蛋白診斷測試市場：按應用進行的估計和趨勢分析

  • 2024 年和 2030 年應用市場佔有率
  • 細分儀表板
  • 全球免疫蛋白診斷檢測市場應用預測
  • 2018-2030 年市場規模、預測及趨勢分析
    • 傳染病檢查
    • 腫瘤學檢測
    • 內分泌檢測
    • 毒理學測試
    • 過敏測試
    • 自體免疫疾病檢測

第 6 章：免疫蛋白診斷市場技術、估計與趨勢分析

  • 2024 年及 2030 年技術市場佔有率
  • 細分儀表板
  • 全球免疫蛋白診斷檢測市場技術展望
  • 2018-2030 年市場規模、預測及趨勢分析
    • 免疫檢測
    • 酵素免疫分析法
    • 化學冷光分析
    • 螢光試驗
    • 免疫濁度測定
    • 免疫蛋白電泳

第7章免疫蛋白質診斷測試市場：按最終用途的估計和趨勢分析

  • 2024 年及 2030 年終端用途市場佔有率
  • 細分儀表板
  • 全球免疫蛋白診斷測試市場前景（依最終用途）
  • 2018-2030 年市場規模、預測及趨勢分析
    • 醫院和診所
    • 診斷實驗室
    • 其他

第 8 章：免疫蛋白診斷市場按分銷管道分類、估計和趨勢分析

  • 分銷通路市場佔有率，2024 年和 2030 年
  • 細分儀表板
  • 全球免疫蛋白診斷檢測市場按通路展望
  • 2018-2030 年市場規模、預測及趨勢分析
    • 直接競標
    • 零售

第 9 章免疫蛋白診斷市場：區域、估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 2024 年主要企業的市場佔有率分析
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • PerkinElmer Inc
    • Bio-Rad Laboratories, Inc
    • Aurora Biomed Inc.
    • Tecan Trading AG
    • Promega Corporation
    • Charles River Laboratories
    • Creative Biolabs
Product Code: GVR-1-68038-501-4

Immunoprotein Diagnostic Testing Market Growth & Trends:

The global Immunoprotein Diagnostic testing market size is expected to reach USD 14.86 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising incidence of chronic diseases.

According to American Heart Association's 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for Immunoprotein Diagnostic is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of Immunoprotein Diagnostic have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

Immunoprotein Diagnostic Testing Market Report Highlights:

  • The immunoglobulin diagnostic tests segment accounted for the largest revenue share of the market of 27.1% in 2024. These tests dominate the immunoprotein diagnostic testing market due to their critical role in diagnosing a wide range of conditions, including immune deficiencies, autoimmune disorders, and infectious diseases.
  • The infectious disease testing segment accounted for the largest revenue share of the market of 24.2% in 2024. Infectious disease testing is in high demand due to the increasing prevalence of infectious diseases, the need for early and accurate diagnosis, and the critical role these tests play in managing public health.
  • The enzyme-based immunoassay segment accounted for the largest revenue share of the market of 25.0% in 2024.
  • The retail sales segment accounted for the largest share of the market of 54.1% in 2024. This growth can be attributed to the increased accessibility and convenience for patients.
  • The hospitals and clinics segment accounted for the largest revenue share of the market of 44.7% in 2024. Hospitals and clinics serve a large number of patients daily, driving a high demand for diagnostic testing services.
  • North America immunoprotein diagnostic testing industry dominated and accounted for a 45.32% share in 2024. The market dominance can be attributed to technological advancements, the high prevalence of chronic diseases, and growing investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test
    • 1.2.2. Application
    • 1.2.3. Technology
    • 1.2.4. End Use
    • 1.2.5. Distribution Channel
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. Application outlook
    • 2.2.3. Technology outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Distribution channel outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoprotein Diagnostic Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of Chronic Diseases
      • 3.2.1.2. Technological Advancements
      • 3.2.1.3. Growing Focus on Personalized Medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Diagnostic Tests
      • 3.2.2.2. Regulatory Challenges
  • 3.3. Immunoprotein Diagnostic Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Immunoprotein Diagnostic Testing Market: Test Estimates & Trend Analysis

  • 4.1. Test Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Immunoprotein Diagnostic Testing Market by Test Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Complement System Proteins Diagnostic Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Free Light Chain Diagnostic Tests
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Haptoglobin Diagnostic Tests
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Immunoglobulin Diagnostic Tests
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Prealbumin Diagnostic Tests
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. C-Reactive Protein (CRP) Diagnostic Tests
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Immunoprotein Diagnostic Testing Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Immunoprotein Diagnostic Testing Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Infectious Disease Testing
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Oncology Testing
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Endocrine Testing
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Toxicology Testing
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Allergy Testing
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Autoimmune Disease Testing
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Immunoprotein Diagnostic Testing Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Immunoprotein Diagnostic Testing Market by Technology Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Radioimmunoassay
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Enzyme Based Immunoassay
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Chemiluminescence Assay
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Immunofluorescence Assay
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Immunoturbidity Assay
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Immunoprotein Electrophoresis
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Immunoprotein Diagnostic Testing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Immunoprotein Diagnostic Testing Market by End Use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Hospitals and Clinics
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Diagnostic Laboratories
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Immunoprotein Diagnostic Testing Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Distribution Channel Market Share, 2024 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Immunoprotein Diagnostic Testing Market by Distribution Channel Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Direct Tender
      • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Retail Sales
      • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Immunoprotein Diagnostic Testing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Target disease prevalence
      • 9.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Target disease prevalence
      • 9.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Target disease prevalence
      • 9.5.3.5. Mexico market estimates and forecasts 2018 to 2030, (USD Million
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Target disease prevalence
      • 9.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Target disease prevalence
      • 9.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Target disease prevalence
      • 9.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Target disease prevalence
      • 9.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Target disease prevalence
      • 9.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Target disease prevalence
      • 9.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Target disease prevalence
      • 9.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Target disease prevalence
      • 9.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Target disease prevalence
      • 9.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Target disease prevalence
      • 9.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Target disease prevalence
      • 9.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. Target disease prevalence
      • 9.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Target disease prevalence
      • 9.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Target disease prevalence
      • 9.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Target disease prevalence
      • 9.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. Target disease prevalence
      • 9.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Target disease prevalence
      • 9.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. Target disease prevalence
      • 9.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Target disease prevalence
      • 9.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. Key company market share analysis, 2024
    • 10.3.2. Agilent Technologies, Inc.
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Danaher Corporation
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Thermo Fisher Scientific Inc
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. PerkinElmer Inc
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Bio-Rad Laboratories, Inc
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Aurora Biomed Inc.
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Tecan Trading AG
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Promega Corporation
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Charles River Laboratories
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Creative Biolabs
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives

List of Tables

  • Table. 1 List of Abbreviation
  • Table. 2 North America immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 3 North America immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 4 North America immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 5 North America immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 6 North America immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 7 U.S. immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 8 U.S. immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 9 U.S. immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 10 U.S. immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 11 U.S. immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 12 Canada immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 13 Canada immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 14 Canada immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 15 Canada immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 16 Canada immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 17 Mexico immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 18 Mexico immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 19 Mexico immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 20 Mexico immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 21 Mexico immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 22 Europe immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 23 Europe immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 24 Europe immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 25 Europe immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 26 Europe immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 27 UK immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 28 UK immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 29 UK immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 30 UK immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 31 UK immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 32 Germany immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 33 Germany immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 34 Germany immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 35 Germany immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 36 Germany immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 37 France immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 38 France immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 39 France immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 40 France immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 41 France immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 42 Italy immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 43 Italy immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 44 Italy immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 45 Italy immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 46 Italy immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 47 Spain immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 48 Spain immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 49 Spain immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 50 Spain immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 51 Spain immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 52 Denmark immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 53 Denmark immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 54 Denmark immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 55 Denmark immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 56 Denmark immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 57 Sweden immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 58 Sweden immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 59 Sweden immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 60 Sweden immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 61 Sweden immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 62 Norway immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 63 Norway immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 64 Norway immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 65 Norway immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 66 Norway immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 67 Asia Pacific immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 68 Asia Pacific immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 69 Asia Pacific immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 70 Asia Pacific immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 71 Asia Pacific immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 72 Japan immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 73 Japan immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 74 Japan immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 75 Japan immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 76 Japan immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 77 China immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 78 China immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 79 China immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 80 China immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 81 China immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 82 India immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 83 India immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 84 India immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 85 India immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 86 India immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 87 Australia immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 88 Australia immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 89 Australia immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 90 Australia immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 91 Australia immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 92 Thailand immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 93 Thailand immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 94 Thailand immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 95 Thailand immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 96 Thailand immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 97 South Korea immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 98 South Korea immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 99 South Korea immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 100 South Korea immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 101 South Korea immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 102 Latin America immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 103 Latin America immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 104 Latin America immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 105 Latin America immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 106 Latin America immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 107 Brazil immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 108 Brazil immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 109 Brazil immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 110 Brazil immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 111 Brazil immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 112 Argentina immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 113 Argentina immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 114 Argentina immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 115 Argentina immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 116 Argentina immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 117 Middle East & Africa immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 118 Middle East & Africa immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 119 Middle East & Africa immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 120 Middle East & Africa immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 121 Middle East & Africa immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 122 South Africa immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 123 South Africa immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 124 South Africa immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 125 South Africa immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 126 South Africa immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 127 Saudi Arabia immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 128 Saudi Arabia immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 129 Saudi Arabia immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 130 Saudi Arabia immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 131 Saudi Arabia immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 132 UAE immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 133 UAE immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 134 UAE immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 135 UAE immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 136 UAE immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
  • Table. 137 Kuwait immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
  • Table. 138 Kuwait immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
  • Table. 139 Kuwait immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
  • Table. 140 Kuwait immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
  • Table. 141 Kuwait immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Immunoprotein Diagnostic Testing: Market outlook
  • Fig. 9 Immunoprotein Diagnostic Testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Immunoprotein Diagnostic Testing Market driver impact
  • Fig. 15 Immunoprotein Diagnostic Testing Market restraint impact
  • Fig. 16 Immunoprotein Diagnostic Testing Market strategic initiatives analysis
  • Fig. 17 Immunoprotein Diagnostic Testing market: Test movement analysis
  • Fig. 18 Immunoprotein Diagnostic Testing market: Test outlook and key takeaways
  • Fig. 19 Complement System Proteins Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Free Light Chain Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Haptoglobin Diagnostic Test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Immunoglobulin Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Prealbumin Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 C-Reactive Protein (CRP) Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Immunoprotein Diagnostic Testing market: Application movement analysis
  • Fig. 26 Immunoprotein Diagnostic Testing market: Application outlook and key takeaways
  • Fig. 27 Infectious Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Oncology Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Endocrine Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Toxicology Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Allergy Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Autoimmune Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Immunoprotein Diagnostic Testing market: Technology movement analysis
  • Fig. 34 Immunoprotein Diagnostic Testing market: Technology outlook and key takeaways
  • Fig. 35 Radioimmunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Enzyme Based Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Chemiluminescence Assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Immunofluorescence Assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Immunoturbidity Assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunoprotein Electrophoresis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Immunoprotein Diagnostic Testing market: End Use movement analysis
  • Fig. 42 Immunoprotein Diagnostic Testing market: End Use outlook and key takeaways
  • Fig. 43 Hospitals and Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Immunoprotein Diagnostic Testing market: Distribution Channel movement analysis
  • Fig. 47 Immunoprotein Diagnostic Testing market: Distribution Channel outlook and key takeaways
  • Fig. 48 Direct Tender market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Retail Sales market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 U.K. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)